KOREA ARLICO PHARM CO.,LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 260660 for the last quarter is 48.82 B KRW, and it's 8.67% higher compared to the previous quarter. The net income of Q3 24 is 1.08 B KRW.